Read + Share
Amedeo Smart
Independent Medical Education
Curik N, Laznicka A, Krizkova J, Suchankova P, et al. Venetoclax in combination with ponatinib for the treatment of asciminib-resistant chronic myeloid leukemia. Leukemia 2025 Aug 26. doi: 10.1038/s41375-025-02732.PMID: 40858806
Email
LinkedIn
Privacy Policy